Mar 6 |
Trxade Group declares $8.00 special dividend
|
Mar 6 |
TRxADE Health, Inc. Announces Special Cash Dividend
|
Feb 20 |
Trxade sells online pharma marketplace, stock rallies 90%
|
Jan 17 |
Trxade Group GAAP EPS of -$0.07, revenue of $2.06M
|
Jan 17 |
Trxade health, Inc files its 3Q 10Q
|
Nov 30 |
TRxADE Health receives Nasdaq notice over delayed Form 10-Q filing
|
Nov 29 |
TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.
|
Oct 17 |
TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.
|